1.17.4.5: vitamin-K-epoxide reductase (warfarin-insensitive)
This is an abbreviated version!
For detailed information about vitamin-K-epoxide reductase (warfarin-insensitive), go to the full flat file.
Word Map on EC 1.17.4.5
-
1.17.4.5
-
anticoagulant
-
coagulation
-
k-dependent
-
carboxylase
-
non-hepatic
-
4-hydroxycoumarins
-
dosing
-
warfarin-resistant
-
vkorc1
-
2,3-epoxide
-
clotting
-
s-warfarin
-
pharmacogenetic
-
dithiothreitol-dependent
-
scottish
-
rodenticide
- 1.17.4.5
-
anticoagulant
-
coagulation
-
k-dependent
- carboxylase
-
non-hepatic
- 4-hydroxycoumarins
-
dosing
-
warfarin-resistant
- vkorc1
- 2,3-epoxide
-
clotting
-
s-warfarin
-
pharmacogenetic
-
dithiothreitol-dependent
-
scottish
-
rodenticide
Reaction
Synonyms
EC 1.1.4.2, non-VKOR, reductase, vitamin K epoxide (warfarin-insensitive), vitamin K 2,3 epoxide reductase, vitamin K epoxide reductase, vitamin K epoxide reductase (warfarin-insensitive), vitamin K epoxide reductase-like1, vitamin KO reductase, VKOR, VKOR-like1, VKORC1L1, VKORL1
ECTree
Advanced search results
Inhibitors
Inhibitors on EC 1.17.4.5 - vitamin-K-epoxide reductase (warfarin-insensitive)
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
additional information
non-VKOR, warfarin-sensitive enzyme, while hVKORL is mainly insensitive to inhibition by warfarin, but about 30% of hVKORL1 is inhibited by 0.005 mM warfarin, VKORL1 is warfarin sensitive, but not affect warfarin dosage requirements
-
additional information
-
non-VKOR, warfarin-sensitive enzyme, while hVKORL is mainly insensitive to inhibition by warfarin, but about 30% of hVKORL1 is inhibited by 0.005 mM warfarin, VKORL1 is warfarin sensitive, but not affect warfarin dosage requirements
-
additional information
-
evaluation of warfarin resistance using TALENs-mediated vitamin K epoxide reductase knockout HEK293 cells, overview
-
additional information
-
VKORC1 mutant Y137F is resistant against inhibition by warfarin, but not against inhibition by other antocoagulants, overview
-